Lantern Pharma Inc (LTRN)
6.35
-0.55
(-7.97%)
USD |
NASDAQ |
May 07, 16:00
6.35
0.00 (0.00%)
After-Hours: 18:43
Lantern Pharma Enterprise Value: 32.81M for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 32.81M |
| May 03, 2024 | 24.76M |
| May 02, 2024 | 17.67M |
| May 01, 2024 | 16.59M |
| April 30, 2024 | 13.48M |
| April 29, 2024 | 11.65M |
| April 26, 2024 | 17.77M |
| April 25, 2024 | 17.34M |
| April 24, 2024 | 16.49M |
| April 23, 2024 | 20.67M |
| April 22, 2024 | 20.14M |
| April 19, 2024 | 16.06M |
| April 18, 2024 | 20.67M |
| April 17, 2024 | 23.04M |
| April 16, 2024 | 23.15M |
| April 15, 2024 | 22.82M |
| April 12, 2024 | 27.33M |
| April 11, 2024 | 30.34M |
| April 10, 2024 | 41.84M |
| April 09, 2024 | 42.05M |
| April 08, 2024 | 42.37M |
| April 05, 2024 | 42.05M |
| April 04, 2024 | 36.25M |
| April 03, 2024 | 51.50M |
| April 02, 2024 | 56.98M |
| Date | Value |
|---|---|
| April 01, 2024 | 60.85M |
| March 28, 2024 | 53.22M |
| March 27, 2024 | 63.75M |
| March 26, 2024 | 66.43M |
| March 25, 2024 | 65.25M |
| March 22, 2024 | 73.09M |
| March 21, 2024 | 55.69M |
| March 20, 2024 | 53.22M |
| March 19, 2024 | 39.15M |
| March 18, 2024 | 65.68M |
| March 15, 2024 | 52.15M |
| March 14, 2024 | 37.65M |
| March 13, 2024 | 32.70M |
| March 12, 2024 | 41.41M |
| March 11, 2024 | 26.58M |
| March 08, 2024 | 47.53M |
| March 07, 2024 | 30.13M |
| March 06, 2024 | 17.67M |
| March 05, 2024 | 10.36M |
| March 04, 2024 | 7.474M |
| March 01, 2024 | 3.284M |
| February 29, 2024 | 10.38M |
| February 28, 2024 | 13.49M |
| February 27, 2024 | 6.943M |
| February 26, 2024 | 4.798M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-17.97M
Minimum
Oct 31 2023
225.72M
Maximum
Mar 17 2021
34.51M
Average
7.407M
Median
Enterprise Value Benchmarks
| Eyenovia Inc | 40.99M |
| Cassava Sciences Inc | 809.07M |
| Alpine Immune Sciences Inc | 3.908B |
| Clearside Biomedical Inc | 68.96M |
| Poseida Therapeutics Inc | 119.45M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.186M |
| Total Expenses (Quarterly) | 4.877M |
| EPS Diluted (Quarterly) | -0.39 |
| Earnings Yield | -23.31% |